Kingsbury Capital Investment Advisors LLC Alpine Immune Sciences, Inc. Transaction History

Kingsbury Capital Investment Advisors LLC

  • $65.6 Million
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$6.71 - $9.52 $195,616 - $277,536
-29,153 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.41 - $13.89 $186,870 - $404,935
29,153 New
29,153 $262,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Kingsbury Capital Investment Advisors LLC Portfolio

Follow Kingsbury Capital Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsbury Capital Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsbury Capital Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email